Allarity Therapeutics Cash Flow Statement (2024-2025) | ALLR

Cash Flow Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -3.84M-1.63M-11.59M8.92M-2.70M-2.32M-2.81M2.30M
Share-based Compensation (Quarter) -0.03M0.02M0.02M0.06M0.14M0.16M0.13M0.05M
Deferred Taxes (Quarter) -0.01M-0.43M
Gains from Sales and Divestitures (Quarter) 0.04M0.04M
Gains from Investment Securities (Quarter) 0.10M11.002.00-0.17M0.03M0.09M0.03M
Non-cash Items (Quarter) 13.000.01M6.003.50M
Cash from Operations (Quarter) -1.40M-7.30M-5.44M-3.21M-2.69M-5.48M-3.41M-3.24M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter) 0.10M0.02M0.06M0.06M0.06M0.03M0.07M0.02M
Depreciation & Amortization (CF) (Quarter) 0.00M0.00M0.01M0.00M0.01M0.01M
Change in Working Capital
Change in Account Payables (Quarter) 2.84M-3.41M-3.05M-0.48M0.18M0.26M-0.00M-1.57M
Change in Accured Expenses (Quarter) 0.24M-0.08M-0.28M3.66M-0.00M-2.32M-0.32M-0.05M
Change in Taxes (Quarter) 0.52M0.25M0.07M-0.82M0.00M0.84M-0.83M
Other Working Capital Changes (Quarter) -0.10M0.02M7.000.32M-0.01M0.85M0.44M0.31M
Financing Activities
Cash from Financing Activities (Quarter) 1.38M26.31M4.87M4.24M11.14M-2.56M2.31M-0.24M
Additional items
Exchange Rate Effect (Quarter) 0.17M-0.08M-0.20M0.34M-0.29M-1.86M0.19M1.28M
Change in Cash (Quarter) -0.02M19.00M-0.57M0.73M8.46M-8.05M-1.10M-3.49M
Free Cash Flow (Quarter) -1.40M-7.30M-5.44M-3.21M-2.69M-5.48M-3.41M-3.24M
Net Cash Flow (Quarter) -0.02M19.00M-0.57M1.03M8.46M-8.05M-1.10M-3.48M